Early Recognition of Relapse and Refractory Response to Myeloma Treatment
Early Recognition of Relapse and Refractory Response to Myeloma Treatment  image
Sep 15, 2021 / 01:00PM - 02:00PM MDT
Mountain West Myeloma Chapter

Event Description

Learn from Dr. Amandeep Godara, a multiple myeloma and amyloidosis specialist based at Huntsman, as he shares with us how to detect relapse or refractory signs early on. What does a relapse really look like? What are the signs of relapse? What does being refractory look like and how soon can it show up on tests? Help us raise awareness for myeloma patients and communities so better treatment decisions can be made quicker. Come with your questions! 

Schedule & Agenda

person
Introductions
01:00PM
Audrey Burton-Bethke and Nico Cheek-O'Donnell
Audrey introduces the meeting agenda and the moderator, Nico. Nico presents our featured speaker, Dr. Amandeep Godara from Hunstman. 
person
Presentation
01:10PM
Dr. Amandeep Godara
Dr. Godara teaches the group how to recognize the signs of relapse early as well the signs of early refractory disease. How can we use this knowledge to aid us in receiving the best care? 
person
Questions and Answers
01:40PM
Audience
Ask Dr. Godara your questions about relapsed and refractory myeloma. 

Speakers & Moderators

The panelist Nico Cheek-O'Donnell
Nico Cheek-O'Donnell

Nico joined the Multiple Myeloma Program at Huntsman Cancer Institute in 2016, as its licensed clinical social worker. Before that, he was a social worker with Intermountain, primarily at LDS Hospital on their inpatient behavioral unit. He earned his Master of Social Work degree at the University of Utah. Originally from New York & Boston, Nico earned undergraduate degrees in Psychology & Theatre from Carleton College in Minnesota. He earned most of his very modest living as a stage actor in Minneapolis and Seattle for eight years, before moving to Utah in 2006. More recently, Nico has used role-play to help train physicians how to navigate especially difficult patient conversations – and to entertain his 13 & 9-year-old kids.

Read Bio
The panelist Amandeep Godara, MBBS
Amandeep Godara, MBBS

Dr. Amandeep Godara completed his hematology-oncology fellowship at Tufts Medical Center with a clinical and research interest in plasma cell disorders. His research focuses on developing new therapeutic targets and tools for assessment of treatment response in multiple myeloma, amyloidosis and other monoclonal gammopathies. His work has been presented at national and international scientific meetings. He was the recipient of Amyloidosis Foundation David Seldin, MD, PhD Memorial Research Grant in 2019. He also received training in blood and marrow transplantation at Stanford University. He completed his medical school at Government Medical College, Aurangabad, India, and his internal medicine residency at Wayne State University. Dr. Godara treats patients with Multiple Myeloma, Amyloidosis, Waldenstrom’s Macroglobulinemia, and other plasma cell disorders.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

+1 800 709 1113

email

Support@healthtree.org

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Legend Biotechnologies
Bristol Myers Squibb
Abbvie
Genentech
GSK
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation for Multiple Myeloma (formerly know as Myeloma Crowd) is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811